Delivery Order SPE2DB20D3303-SPE2DB26FY2B0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Sirolimus 0.5 mg tablets (100 count) with a ceiling value of $1,393.36. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is scheduled for ultimate completion by July...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Sirolimus 0.5 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,496.55. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sirolimus is an immunosuppressant medication...
- The Defense Logistics Agency awarded a delivery order valued at $1,287.56 to AmerisourceBergen Drug Corp for Sirolimus 0.5 mg tablets (100-count packages) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Sirolimus is an immunosuppressant medication commonly used in transplant medicine and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Sirolimus 1 mg/ml solution in a 60 ml quantity, with a contract ceiling value of $1,085.44. This non-set-aside delivery order represents a firm fixed-price procurement executed with an ultimate completion date of October 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,872.18 to AmerisourceBergen Drug Corp for the supply of Sirolimus 1 mg/ml Solution in 60ml quantities. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sirolimus 1 mg/ml solution in 60 ml containers. The contract has a firm-fixed price of $2,432.75 and an ultimate completion date of May 28, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $4,196.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. AmerisourceBergen was awarded the delivery order to provide Sirolimus 1 mg/ml solution, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen, valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,132 to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 1 mg sirolimus. The delivery order was issued under an existing prime vendor contract vehicle and calls for shipment of the pharmaceutical product to a facility in Conshohocken, Pennsylvania, with performance required between July 11-12, 2023. DLA will provide the funding for this order in support of its medical supply...
- This federal contract award, with a ceiling value of $1,227.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of SIROLIMUS 1 MG TABLET 100S, a pharmaceutical product, with a period of performance through March 27, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $2,213.68 firm fixed price delivery order contract to supply 100 tablets of the pharmaceutical Sirolimus 1 mg. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day contract runs from August 28 through August 29, 2023 to support the Department of Defense's pharmaceutical procurement needs. As the prime contractor, Amerisourcebergen will leverage its extensive distribution...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2B0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Sirolimus 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,007.40 and is classified as a firm fixed price delivery order with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen supplies an extensive range of medications and medical commodities to support military healthcare systems worldwide. The company's contract portfolio with the DLA demonstrates its established capability to fulfill federal pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/4/25 |